SoftOx Solutions AS will hold an Extraordinary General Meeting on 15th December
2025 at 10 am (CEST). The notice convening the Extraordinary General Meeting,
including the agenda and the board's proposals for the matters to be dealt with,
is enclosed with this notification and will be sent to all shareholders.  

Relevant documents referred to in the notice are also made available at
https://soft-ox.com/stock-market-announcements/

For further information, please contact:  
Ulrik Spork, COB Soft Solutions AS, +45 31 38 83 87  
Ingrid Juven, CFO SoftOx Solutions AS, +47 918 76 165  
Mail: ir@soft-ox.com  

About SoftOx Solutions AS:
SoftOx Solutions AS (ticker: SOFTX) is a clinical-stage pharmaceutical company
listed on Euronext Growth Oslo. The company is developing highly effective
pan-antimicrobial pharmaceuticals targeting bacteria, viruses, and fungi. The
technology is based on extensive research and development in partnership with
leading Nordic research institutes.